Ads
related to: productive cough syrup in india list of drugs treatment options
Search results
Results From The WOW.Com Content Network
Ambroxol is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered as an active ingredient in cough syrup. It was patented in 1966 and came into medical use in 1979. [1]
Corex is a cough syrup sold by Pfizer Inc. [1] It is available in India, Pakistan, Bangladesh and a few other South Asian countries. Corex is a prescribed medicine. Corex is a prescribed medicine. Its active ingredients are chlorpheniramine maleate and codeine phosphate .
In 1999, Dr. Reddy's joined the Indian Pharmaceutical Alliance as a founding member in an effort to promote the development of generic drugs in India. [ 11 ] [ 12 ] Wockhardt is the first company outside the US and Europe to manufacture recombinant human insulin .
The deaths of 12 children in northern India between December 2019 and January 2020, police allege, were caused by adulterated cough syrup made by drugmaker Digital Vision. Indian drugs regulators ...
It also includes drugs which are marketed as cough suppressants or antitussives, but their effectiveness in reducing cough symptoms is unclear or minimal. [ 1 ] [ 2 ] [ 3 ] While they have been used by 10% of American children in any given week, they are not recommended in Canada or the United States in children six years or younger because of ...
The new rule highlights how governments are reassessing their reliance on India's $42 billion pharmaceutical industry since the contamination came to light l Gambia tightens rules for Indian drugs ...
Codeine is also present in various cough syrups as codeine phosphate including chlorpheniramine maleate. Pure codeine is also available as codeine sulphate tablets. Codeine containing cough medicine has been banned in India with effect from 14 March 2016. The Ministry of Health and Family Welfare has found no proof of its efficacy against cough ...
NEW DELHI (Reuters) -India has found violations related to manufacturing and laboratory practices at drugmaker Riemann Labs, whose cough syrup was linked to the deaths of children in Cameroon, a ...